Research Groups

Section of Molecular Pathology

Recent Publications - 12 most recent publications

1. Wang Q., Satomi K., Oh J. E., Hutter B., Brors B., Diessl N., Liu H. K., Wolf S., Wiestler O., Kleihues P., Koelsch B., Kindler-Rohrborn A., Ohgaki H. (2016) Braf Mutations Initiate the Development of Rat Gliomas Induced by Postnatal Exposure to N-Ethyl-N-Nitrosourea Am J Pathol; 186(10):2569-76. PMID: 27658714

2. Gramatzki D., Dehler S., Rushing E. J., Zaugg K., Hofer S., Yonekawa Y., Bertalanffy H., Valavanis A., Korol D., Rohrmann S., Pless M., Oberle J., Roth P., Ohgaki H., Weller M. (2016) Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009 Cancer; 122(14):2206-15. PMID: 27088883

3. Oh J. E., Ohta T., Nonoguchi N., Satomi K., Capper D., Pierscianek D., Sure U., Vital A., Paulus W., Mittelbronn M., Antonelli M., Kleihues P., Giangaspero F., Ohgaki H. (2016) Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma Brain Pathol; 26(4):517-22. PMID: 26443480

4. Zhao F., Ohgaki H., Xu L., Giangaspero F., Li C., Li P., Yang Z., Wang B., Wang X., Wang Z., Ai L., Zhang J., Luo L., Liu P. (2016) Molecular subgroups of adult medulloblastoma: a long-term single-institution study Neuro Oncol; 18(7):982-90. PMID: 27106407

5. Louis D. N., Perry A., Reifenberger G., von Deimling A., Figarella-Branger D., Cavenee W. K., Ohgaki H., Wiestler O. D., Kleihues P., Ellison D. W. (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary Acta Neuropathol; 131(6):803-20. PMID: 27157931

6. Stewart B. W., Bray F., Forman D., Ohgaki H., Straif K., Ullrich A., Wild C. P. (2016) Cancer prevention as part of precision medicine: 'plenty to be done' Carcinogenesis; 37(1):2-9. PMID: 26590901

7. Parroche P., Roblot G., Le Calvez-Kelm F., Tout I., Marotel M., Malfroy M., Durand G., McKay J., Ainouze M., Carreira C., Allatif O., Traverse-Glehen A., Mendiola M., Pozo-Kreilinger J. J., Caux C., Tommasino M., Goutagny N., Hasan U. A. (2016) TLR9 re-expression in cancer cells extends the S-phase and stabilizes p16(INK4a) protein expression Oncogenesis; 5(7):e244. PMID: 27454079

8. Walsh K. M., Ohgaki H., Wrensch M. R. (2016) Epidemiology Handb Clin Neurol; 3-18. PMID: 26948345

9. Oh J.E., Ohta T., Satomi K., Foll M., Durand G., McKay J., Le Calvez-Kelm F., Mittelbronn M., Brokinkel B., Paulus W., Ohgaki H. (2015) Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas J Neuropathol. Exp. Neurol; 74(10):952-959. PMID: 26360373

10. Baumgarten P., Harter P.N., Tonjes M., Capper D., Blank A.E., Sahm F., von Deimling A., Kolluru V., Schwamb B., Rabenhorst U., Starzetz T., Kogel D., Rieker R.J., Plate K.H., Ohgaki H., Radlwimmer B., Zornig M., Mittelbronn M. (2014) Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosity Neuropathol. Appl. Neurobiol; 40(2):205-216.

11. Corbex M., Bouzbid S., Traverse-Glehen A., Aouras H., McKay-Chopin S., Carreira C., Lankar A., Tommasino M., Gheit T. (2014) Prevalence of papillomaviruses, polyomaviruses, and herpesviruses in triple-negative and inflammatory breast tumors from algeria compared with other types of breast cancer tumors PLoS ONE; 9(12):e114559.

12. Fiaschetti G., Abela L., Nonoguchi N., Dubuc A.M., Remke M., Boro A., Grunder E., Siler U., Ohgaki H., Taylor M.D., Baumgartner M., Shalaby T., Grotzer M.A. (2014) Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma Br J Cancer; 110(3):636-647.